May 19, 2017 11:32 am UTC| Business
LEXINGTON, Mass., May 19, 2017 -- T2 Biosystems, Inc., (NASDAQ:TTOO), a company developing innovative diagnostic products to improve patient health and deliver a strong economic return to healthcare institutions,...
May 19, 2017 11:32 am UTC| Business
LEXINGTON, Mass., May 19, 2017 -- T2 Biosystems, Inc., (NASDAQ:TTOO), a company developing innovative diagnostic products to improve patient health and deliver a strong economic return to healthcare institutions,...
May 19, 2017 11:32 am UTC| Business
BELLEVUE, Wash., May 19, 2017 -- J. Braxton Carter, Executive Vice President Chief Financial Officer of T-Mobile US, Inc. (NASDAQ:TMUS) will present and provide a business update at 10:00 a.m. Eastern Daylight Time on...
May 19, 2017 11:32 am UTC| Business
BELLEVUE, Wash., May 19, 2017 -- J. Braxton Carter, Executive Vice President Chief Financial Officer of T-Mobile US, Inc. (NASDAQ:TMUS) will present and provide a business update at 10:00 a.m. Eastern Daylight Time on...
May 19, 2017 11:32 am UTC| Business
BELLEVUE, Wash., May 19, 2017 -- J. Braxton Carter, Executive Vice President Chief Financial Officer of T-Mobile US, Inc. (NASDAQ:TMUS) will present and provide a business update at 10:00 a.m. Eastern Daylight Time on...
May 19, 2017 11:31 am UTC| Business
CRANBURY, N.J., May 19, 2017 -- Amicus Therapeutics, Inc. (Nasdaq:FOLD), has completed the analysis plan for the primary endpoints in the blinded ongoing Phase 3 clinical study (ESSENCE) of the novel topical medicine...
May 19, 2017 11:31 am UTC| Business
CRANBURY, N.J., May 19, 2017 -- Amicus Therapeutics, Inc. (Nasdaq:FOLD), has completed the analysis plan for the primary endpoints in the blinded ongoing Phase 3 clinical study (ESSENCE) of the novel topical medicine...